BOLT BIOTHERAPEUTICS INC (BOLT)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.900.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BOLT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 4.7 | 7.7 | 7.7 | 7.9 | 5.7 | 1.3 | 0.2 |
| Total Revenues | 4.7 | 7.7 | 7.7 | 7.9 | 5.7 | 1.3 | 0.2 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 21.5 | 28.5 | 57.5 | 61.5 | 73.1 | 75.7 | 40.4 |
| Operating Income | (30.8) | (36.1) | (73.0) | (76.2) | (90.3) | (92.8) | (49.2) |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | 2.0 | 2.7 | 9.9 | 7.0 | 2.2 | (5.8) | (11.5) |
| Asset Writedown | — | — | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | — | (33.4) | — | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (28.7) | (33.4) | (63.1) | (69.2) | (88.1) | (98.6) | (60.7) |
| Per Share | |||||||
| Basic EPS | (17.00) | (17.85) | (1.65) | (1.83) | (2.36) | (2.97) | — |
| Diluted EPS | (17.00) | (17.85) | (1.65) | (1.83) | (2.36) | (2.97) | — |
| Revenue per Share | 2.78 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 1.7 | 1.9 | 38.2 | 37.8 | 37.4 | 33.2 | 2.0 |
| Diluted Weighted Avg Shares | 1.7 | 1.9 | 38.2 | 37.8 | 37.4 | 33.2 | — |
| Supplemental | |||||||
| EBITDA | — | (34.8) | (71.3) | (74.3) | (88.7) | (91.6) | (48.6) |
| EBIT | (30.8) | (36.1) | (73.0) | (76.2) | (90.3) | (92.8) | (49.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.